Results of SMSNA survey regarding complications following intralesional injection therapy with collagenase clostridium histolyticum for Peyronie’s disease

Although Peyronie’s disease (PD) was recorded in the medical history more than 200 years ago, its primary management modality has been always surgery without any evidence based alternative until now. Despite the numerous medical treatment options offered to patients in the active phase of the disease (vitamin E, colchicine, pentoxifylline, PABA, NSAI), no oral medical treatment proved useful in meaningful penile curvature improvement in the active phase (1).